RSV Vaccination in Older Adults (50, 75+) — 2025–2026 Guide for Pharmacies & Patients
Until recently, respiratory syncytial virus (RSV) was widely regarded as a childhood infection. That changed as surveillance revealed its substantial toll on older adults, especially those with heart or lung disease. Each year, RSV is responsible for an estimated 60,000–160,000 hospitalizations and 6,000–10,000 deaths among U.S. adults aged 65 and older. These figures are comparable […]
RSV Vaccination in Older Adults (50, 75+) — 2025–2026 Guide for Pharmacies & Patients Read More »